This newest insulin pump system offers the company's most advanced SmartGuard™ technology, as featured in the MiniMed™ 670G system, with the added benefits of smartphone connectivity and an ...

Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be ...

Medtronic and the FDA left an insulin pump with a potentially deadly vulnerability on the market—until researchers who found the flaw showed how bad it could be.

Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps DUBLIN, April 21, 2023 /PRNewswire ...

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an ...

Medtronic plc’s insulin pump adds more than six hours to the time-in-range for people with type 1 diabetes compared to the current standard of care, a recently published study found. The closed loop ...